EGF c.2449A>C ;(p.T817P)

Variant ID: 4-110904655-A-C

NM_001963.4(EGF):c.2449A>C;(p.T817P)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues.

Nature Communications
Abelin, Jennifer G JG; Bergstrom, Erik J EJ; Rivera, Keith D KD; Taylor, Hannah B HB; Klaeger, Susan S; Xu, Charles C; Verzani, Eva K EK; Jackson White, C C; Woldemichael, Hilina B HB; Virshup, Maya M; Olive, Meagan E ME; Maynard, Myranda M; Vartany, Stephanie A SA; Allen, Joseph D JD; Phulphagar, Kshiti K; Harry Kane, M M; Rachimi, Suzanna S; Mani, D R DR; Gillette, Michael A MA; Satpathy, Shankha S; Clauser, Karl R KR; Udeshi, Namrata D ND; Carr, Steven A SA
Publication Date: 2023-04-03

Variant appearance in text: EGF: T817P
PubMed Link: 37012232
Variant Present in the following documents:
  • 41467_2023_37547_MOESM12_ESM.xlsx, sheet 3
  • 41467_2023_37547_MOESM12_ESM.xlsx, sheet 2
View BVdb publication page



Exome sequencing of glioblastoma-derived cancer stem cells reveals rare clinically relevant frameshift deletion in MLLT1 gene.

Cancer Cell International
Marei, Hany E HE; Althani, Asmaa A; Afifi, Nahla N; Hasan, Anwarul A; Caceci, Thomas T; Felsani, Armando A; Tringali, Giuseppe G; Cifola, Ingrid I; Pozzoli, Giacomo G; Cenciarelli, Carlo C
Publication Date: 2022-01-07

Variant appearance in text: EGF: Thr817Pro
PubMed Link: 34996478
Variant Present in the following documents:
  • Main text
  • 12935_2021_Article_2419.pdf
View BVdb publication page



Exome sequencing of glioblastoma-derived cancer stem cells reveals rare clinically relevant frameshift deletion in MLLT1 gene.

Cancer Cell International
Marei, Hany E HE; Althani, Asmaa A; Afifi, Nahla N; Hasan, Anwarul A; Caceci, Thomas T; Felsani, Armando A; Tringali, Giuseppe G; Cifola, Ingrid I; Pozzoli, Giacomo G; Cenciarelli, Carlo C
Publication Date: 2022-01-07

Variant appearance in text: EGF: Thr817Pro
PubMed Link: 34996478
Variant Present in the following documents:
  • Main text
  • 12935_2021_Article_2419.pdf
View BVdb publication page



Proteogenomics Reveals Perturbed Signaling Networks in Malignant Melanoma Cells Resistant to BRAF Inhibition.

Molecular & Cellular Proteomics : Mcp
Schmitt, Marisa M; Sinnberg, Tobias T; Bratl, Katrin K; Zittlau, Katharina K; Garbe, Claus C; Macek, Boris B; Nalpas, Nicolas C NC
Publication Date: 2021-10-19

Variant appearance in text: EGF: T817P
PubMed Link: 34673281
Variant Present in the following documents:
  • mmc2.xlsx, sheet 11
View BVdb publication page



Proteogenomics Reveals Perturbed Signaling Networks in Malignant Melanoma Cells Resistant to BRAF Inhibition.

Molecular & Cellular Proteomics : Mcp
Schmitt, Marisa M; Sinnberg, Tobias T; Bratl, Katrin K; Zittlau, Katharina K; Garbe, Claus C; Macek, Boris B; Nalpas, Nicolas C NC
Publication Date: 2021

Variant appearance in text: EGF: T817P
PubMed Link: 34673281
Variant Present in the following documents:
  • mmc2.xlsx, sheet 11
View BVdb publication page



Genomic Variation in IbA10G2 and Other Patient-Derived Cryptosporidium hominis Subtypes.

Journal Of Clinical Microbiology
Sikora, Per P; Andersson, Sofia S; Winiecka-Krusnell, Jadwiga J; Hallström, Björn B; Alsmark, Cecilia C; Troell, Karin K; Beser, Jessica J; Arrighi, Romanico B G RB
Publication Date: 2017-03

Variant appearance in text: EGF: T817P
PubMed Link: 28003424
Variant Present in the following documents:
  • Main text
View BVdb publication page